TSW
AUXL

Thompson Siegel & Walmsley’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Thompson Siegel & Walmsley’s Portfolio AUXL Stock Details AUXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-36,500
Closed -$732K – 720
2014
Q2 		$732K Buy
36,500
+25,700
+238% +$589K 0.01% 298
2014
Q1 		$294K Buy
+10,800
New +$287K 0.01% 353

Other funds holding AUXL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return

Thompson Siegel & Walmsley's AUXL Position: Q3 2014 in Review

Thompson Siegel & Walmsley sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q3 2014, closing a stake of 36,500 shares — an estimated $732K sold.

Thompson Siegel & Walmsley first reported a position in AUXL in Q1 2014 and held it in 2 quarters. The position peaked at $732K in Q2 2014. 150 funds tracked by Wall St. Rank hold AUXL as of Q3 2014.

  • Thompson Siegel & Walmsley reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 36,500 AUXILIUM PHARAMCEUTICALS INC shares in Q3 2014, an estimated $732K.
  • Thompson Siegel & Walmsley first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q1 2014 and held it in 2 quarters.
  • Thompson Siegel & Walmsley's AUXILIUM PHARAMCEUTICALS INC position peaked at $732K in Q2 2014.
  • 150 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q3 2014.

Based on Thompson Siegel & Walmsley's 13F filing for Q3 2014, filed 12 Nov 2014.